A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

BACKGROUND: Long-acting muscarinic antagonist/long-acting β(2)-agonist combinations are recommended for patients whose chronic obstructive pulmonary disease (COPD) is not managed with monotherapy. We assessed the efficacy and safety of glycopyrrolate (GP)/formoterol fumarate (FF) fixed-dose combinat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Res
Hlavní autoři: Reisner, Colin, Fabbri, Leonardo M., Kerwin, Edward M., Fogarty, Charles, Spangenthal, Selwyn, Rabe, Klaus F., Ferguson, Gary T., Martinez, Fernando J., Donohue, James F., Darken, Patrick, St. Rose, Earl, Orevillo, Chad, Strom, Shannon, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216561/
https://ncbi.nlm.nih.gov/pubmed/28061907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0491-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky